Oral budesonide in the treatment of primary sclerosing cholangitis

American Journal of Gastroenterology

Volumn 95, Issue 9, 2000, Pages 2333-2337

  Angulo, Paul ^a   Batts, Kenneth P ^a   Jorgensen, Roberta A ^a   LaRusso, Nicholas A ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BUDESONIDE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ALOPECIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LIVER DISEASE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; OSTEOPOROSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AGED; ALKALINE PHOSPHATASE; ANTI-INFLAMMATORY AGENTS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; BIOPSY; BUDESONIDE; CHOLANGITIS, SCLEROSING; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; SAFETY;

EID: 0033830021     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)01115-1     Document Type: Article

References (19)

1. Primary sclerosing cholangitis
2. The combination of prednisone and colchicine in patients with primary sclerosing cholangitis
3. A pilot double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss
4. Drug development in inflammatory bowel disease: Budesonide - A model of targeted therapy
5. Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli budesonide study group
6. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: A dose-ranging study. U.S. budesonide enema study group
7. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants
8. High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack
9. Oral budesonide for treatment of autoimmune chronic active hepatitis
10. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis
11. Ursodiol for primary sclerosing cholangitis
12. Primary sclerosing cholangitis
13. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
14. Primary sclerosing cholangitis: Refinement and validation of survival models
15. Natural history and prognostic variables in primary sclerosing cholangitis
16. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
17. Bone disease in liver transplant recipients: Incidence, timing, and risk factors
18. Budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
19. Glucocorticoids-induced osteoporosis: Pathogenesis and management